CRISPR Therapeutics vs Primogene
CRISPR Therapeutics vs Primogene, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and Primogene on 39/100.
Where each one leads
CRISPR Therapeutics
- our overall score: 64/100 against 39/100
- agent readiness: 44/100 against 21/100
- funding raised: $547M against $4.1M
Primogene
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CRISPR Therapeutics | Primogene |
|---|---|---|
| What it is | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. | Enabling sustainable and scalable manufacturing of complex, high-value biomolecules through enzymatic biomanufacturing. |
| Category | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals | Biotechnology, Health, Nutrition, Personal Care |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2013 | 2023 |
| Headquarters | Zug, Switzerland | Leipzig, Germany |
| Status | Active | Active |
Size, funding and growth
| Measure | CRISPR Therapeutics | Primogene |
|---|---|---|
| Total funding | $547M | $4.1M |
| Latest round | Series B | Seed |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CRISPR Therapeutics | Primogene |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 39/100 |
| Traction | 40/100 | 33/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 13/100 | 13/100 |
| Quality | 88/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 67/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CRISPR Therapeutics | Primogene |
|---|---|---|
| Hosting | Self Managed | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CRISPR Therapeutics vs Primogene: common questions
Which is better, CRISPR Therapeutics or Primogene?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do CRISPR Therapeutics and Primogene compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 39/100), agent readiness (44/100 against 21/100), funding raised ($547M against $4.1M).
Read the full CRISPR Therapeutics review and pricing or the Primogene review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.